IPO Premiums
IPO calendar
PDPARListed

Par Drugs and Chemicals Limited

Fixed Price IPO · NSE

Price band
₹51 - ₹51
Lot size
2,000 shares
Issue amount
₹9 cr
Total subscription
0×
Current price₹164.95
Listing price ₹52.9
Watch live price ↗
Opens
3 May 2019
Closes
8 May 2019
Allotment
13 May 2019
Listing
16 May 2019

Offer at a glance

Issue overview

Issue size
16,72,000 shares
Face value
₹10 per share
Minimum investment
₹1,02,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE
Maximum investment
₹1,02,000
Issue type
Fixed Price IPO
Shares before issue
44,80,318
Shares after issue
61,52,318

Lot sizes

CategoryLotsSharesAmount
RETAIL11₹1,02,000
HNI22₹2,04,000

Share reservation

Market Maker5.02%
HNI46.53%
RETAIL46.65%
Employee1.79%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
02,0004,0006,000Mar-16 · Revenue: 3,326.43Mar-16 · Profit after tax: 42.18Mar-16Mar-17 · Revenue: 4,880.9Mar-17 · Profit after tax: 184.78Mar-17Mar-18 · Revenue: 4,241.65Mar-18 · Profit after tax: 149.53Mar-18Mar-19 · Revenue: 4,641.2Mar-19 · Profit after tax: 241.88Mar-19
RevenueProfit after tax

Company information

Company profile

Par Drugs and Chemicals Limited, incorporated in 1999 and based in Gujarat, is engaged in the manufacturing and development of active pharmaceutical ingredients (APIs) and fine chemicals for both domestic and international markets. Its APIs are used in tablets, capsules, and other finished dosages, and it also produces various antacid molecules. The company operates two manufacturing facilities in Ankleshwar and Bhavnagar, Gujarat, and offers a portfolio of 6 fine chemicals and 12 API products sold across 17 countries. Key customers include Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, international sales accounted for 86.88% of total revenue, while domestic sales contributed 13.12%. The company maintains a testing laboratory to ensure quality standards and provides drying operations to convert liquid products into powders for its clients.

Strengths

  • Diversified Product Range: Offers a wide variety of products.
  • International Presence: Operates in global markets.
  • Efficient Distribution: Prompt and reliable sales and distribution network.
  • Proven Track Record: Established history of strong performance.
  • Strong Chemistry Capabilities: Expertise in chemical processes and development.

Promoters

Mr. Falgun Vallabhbhai Savani

Mr. Jignesh Vallabhbhai Savani

Registrar & documents

Lead manager

Pantomath Capital Advisor Private Limited

Registered office

805, Dwarkesh Complex, R.C. Dutt Road, Alkapuri, Vadodara-390 007,

+91 265 2332018

[email protected]Company website ↗

Understanding PAR IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.